Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality-Reference-Cited by-同舟云学术

Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality

Published:2017-12-18 Issue:1 Volume:52 Page:27-37
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Hugosson Jonas¹,Godtman Rebecka Arnsrud¹,Carlsson Sigrid V.¹²³,Aus Gunnar⁴,Grenabo Bergdahl Anna¹,Lodding Pär¹,Pihl Carl-Gustaf⁵,Stranne Johan¹^ORCID,Holmberg Erik⁶,Lilja Hans²⁷⁸⁹¹⁰

Affiliation:

1. Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden;

2. Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA;

3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

4. Department of Urology, Carlanderska Hospital, Gothenburg, Sweden;

5. Department of Pathology, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden;

6. Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden;

7. Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

8. Department of Medicine (Genitourinary Oncology Service), Memorial Sloan Kettering Cancer Center, New York, NY, USA;

9. Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK;

10. Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden

Funder

Swedish Cancer Society

Swedish Research Council

Sahlgrenska University Hospital

National Cancer Institute

Sidney Kimmel Center for Prostate and Urologic Cancers

Prostate Cancer Foundation

Oxford Biomedical Research Centre Program in the UK

Fundacion Federico SA

AFA insurance

National Institutes of Health

Memorial Sloan Kettering Cancer Center

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21681805.2017.1411392

Reference31 articles.

1. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

2. Prostate-Cancer Mortality at 11 Years of Follow-up

3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

4. U.S. Preventive Services Task Force. Draft recommendation statement: prostate cancer: screening. April 2017. [Internet]; Available from: https://www.uspreventiveservicestaskforce.org/Page/Docu-ment/RecommendationStatementDraft/prostate-cancer-screening1

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application and optimization of prostate-specific antigen screening strategy in the diagnosis of prostate cancer: a systematic review;Frontiers in Oncology;2024-01-09

2. Barriers and facilitators of shared decision-making in prostate cancer screening in primary care: A systematic review;Preventive Medicine Reports;2024-01

3. Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs;Journal of Personalized Medicine;2023-12-01

4. Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-11

5. Men’s Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy;European Urology Oncology;2023-11